HOME >> MEDICINE >> NEWS
New study raises questions about the number of people in the UK who could be incubating vCJD

A team of UK scientists found that 3 out of 12,674 stored appendix and tonsil samples showed evidence of the prion protein associated with vCJD, but urge caution about the way these results are interpreted. The research is published this week in The Journal of Pathology.

The study aimed to help health policymakers estimate the numbers of people who could become ill from vCJD by assessing the possible numbers of people in the UK who might be incubating the disease. Based on the three positives and calculations in the highest risk group (those aged 10-30), the researchers estimate that about 3,800 individuals in the UK would test positive.

Although the scientists are certain that prion proteins were present in three samples, only one showed a pattern of prion accumulation that resembled that seen in tissue of known vCJD cases. The other two had different patterns of accumulation, so their significance is uncertain. However, prion protein accumulation has not yet been described in any other disease, so data from these two samples cannot be dismissed.

Lead author of the paper David Hilton, who works in the Department of Histopathology at Derriford Hospital, Plymouth, said "Our findings need to be interpreted with caution, but cannot be discounted. There is still much to learn about vCJD and presence of the protein in these tissue samples does not necessarily mean that those affected will go on to develop vCJD. It is important that we clarify the significance of these findings by prospective screening of fresh tonsillectomy tissue"

In contrast to these high estimates of possible future incidence, clinical cases of vCJD remain low and seem to be in decline. "Although the numbers of cases are currently in decline, the possibility of further rises cannot be excluded," say the authors.

"The study it also reinforces the importance of measures taken by the UK Department of Health to reduce the risk of spread of vCJD via blood products a
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
21-May-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
(Date:2/26/2015)... NJ (PRWEB) February 26, 2015 A ... The practice is offering the following 50 year ... $90 for their choice of Sonic Care Diamond Clean ... $199, $179 respectively). The cost is $2895 for ... that require more than ten treatment procedures are priced ...
(Date:2/26/2015)... Scotch Plains, NJ (PRWEB) February 26, 2015 ... a “NJ Top Dentist” for Dr. David Caggiano! ... education, experience and interests. Combining his background in ... seven years of experience as a general dentist allows ... the toughest orthodontic situations. He was named Orthodontic ...
(Date:2/26/2015)... The hip resurfacing procedure at Texas ... resident John Short to resume his active lifestyle, it has ... climb Mt. Kilimanjaro, the highest free-standing mountain in the world, ... in his late 20s, Short suffered from early onset degeneration. ... sockets were bone on bone. , Then about five ...
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 Beckman ... “Diversity of extracellular vesicles and their cargo in cell-to-cell ... vesicles and their relevance for cell-to-cell communication. The webinar ... March 4, 2015 at 8:00am PT. , Every cell ... extracellular vesicles (EVs) , often called “exosomes” or “microvesicles.” ...
(Date:2/26/2015)... 2015 2015 Deep Market Research ... and in-depth study on the current state of ... focus on the Chinese situation. , Major companies ... & Co.KG, Hu-Friedy, Medisporex, Towne Brothers, Teleflex Medical, ... Weirong Medical Equipment, Shuanglu, Changshu Henry Medical Instrument, ...
Breaking Medicine News(10 mins):Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3
(Date:2/26/2015)... Editor Note: For more ... Investor-Edge has initiated coverage on the following ... Teva Pharmaceutical Industries Ltd (NYSE: TEVA ), ... Inc. (NYSE: AGN ), and Depomed Inc. ... Johnson and Johnson can be accessed at http://get.Investor-Edge.com/pdf/?c=Johnson%20and%20Johnson&d=26-Feb-2015&s=JNJ ...
(Date:2/26/2015)... , Feb. 26, 2015  MEI Pharma, Inc. (Nasdaq: ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at the Cowen and Company 35 th ... at 10:40 a.m. Eastern time from the Boston Marriott Copley ... at www.meipharma.com . A replay will be available approximately ...
(Date:2/26/2015)... CITY , Feb. 26, 2015  Great Basin ... launched a "best efforts" follow-on offering of up to ... of one share of Series E preferred stock and ... preferred stock will be convertible into four shares of ... exercisable into one share of common stock at an ...
Breaking Medicine Technology:Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
Cached News: